Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Postmortem Imaging × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Surveys and Questionnaires 245 Blood Specimen Collection 131 Gene Expression Profiling 86 Interviews as Topic 75 Immunohistochemistry 67 Polymerase Chain Reaction 55 Surgical Procedures, Operative 52 Microarray Analysis 49 Magnetic Resonance Spectroscopy 49 Radiotherapy 45 Flow Cytometry 43 Drug Therapy 41 Amplified Fragment Length Polymorphism Analysis 41 Observation 36 Biopsy 36 Reverse Transcriptase Polymerase Chain Reaction 34 Data Collection 32 Bevacizumab 32 Psychiatric Rehabilitation 26 Therapeutics 24 Nivolumab 24 Sorafenib 23 In Situ Hybridization, Fluorescence 23 palbociclib 22 Neoadjuvant Therapy 22 enzalutamide 21 Focus Groups 21 Docetaxel 21 Rituximab 20 Paclitaxel 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04079283 2020-04-02

RIREP

Tianjin Medical University Cancer Institute and Hospital

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡